This research is Trending!
View all ESC 2026 trials
Immediate Ambulatory Electrocardiographic Monitoring in Syncope
Key result
Immediate 14-day wearable ECG monitoring fails to reduce syncope episodes at one year versus standard practice.
- IRR 0.89
- 95% CI 0.68 to 1.18
- P=0.42
- n=2,234
Why the trial?
Unexplained syncope often goes undiagnosed for months under standard monitoring, delaying treatment of underlying arrhythmias. ASPIRED asked whether immediate enhanced ambulatory ECG monitoring shortens the time to diagnosis and improves management.
Does 14-day ambulatory ECG monitoring reduce the mean number of patient-reported episodes of syncope at 1 year in adults with unexplained syncope after emergency department evaluation?
Population
2,234 adults with syncope unexplained after ED evaluation (mean age 58.3)
Comparison
Immediate 14-day ambulatory ECG monitoring vs standard care
Design
Open-label randomized controlled trial (1:1) at 45 UK hospitals
Follow-up
1 year
Authors
Discussion
Key questions
No takes yet. Share an insight, caveat, or question.
Where experts stand
ASPIRED missed its primary endpoint of reducing syncope recurrence, but experts are divided on whether the mortality signal and doubled arrhythmia detection make early monitoring practice-changing despite the neutral headline result.
Immediate prolonged ECG monitoring after unexplained syncope did not reduce fainting episodes at one year, but it found far more arrhythmias and was linked to lower mortality. Some experts see the trial as misleadingly framed around syncope recurrence when the real story is earlier diagnosis and a striking mortality difference. The open question is whether these secondary signals are strong enough to reshape emergency-department syncope pathways.
Agreement
Multiple clinicians highlight that while the primary syncope-recurrence endpoint was negative, the trial showed markedly improved arrhythmia detection and a mortality benefit favoring early monitoring.
4 clinicians say this directly
Main debate
Is ASPIRED a neutral trial or a practice-changer hiding behind the wrong primary endpoint?
Practice-changing despite neutral primary endpoint3
The real value is earlier diagnosis and lower mortality, not preventing another faint.vs
Neutral result on the primary endpoint3
Monitoring did not significantly reduce syncope episodes at one year compared with standard care.Still unclear
Whether the all-cause mortality signal is robust enough to be considered a true treatment effect or a chance finding in a trial not powered for that endpoint. It also remains unclear whether guidelines will incorporate early prolonged monitoring into ED syncope pathways based on secondary outcomes alone.
Key expert perspectives
The abstract is misleading: the real finding is that monitoring cuts one-year mortality
Calls the ASPIRED abstract misleading for leading with the neutral syncope-recurrence result. Argues the key finding is that Zio monitoring after syncope reduces one-year mortality, which should be the headline takeaway.
Distilled from their postX post
ASPIRED may change ED syncope pathways: the benefit is diagnosis, not preventing another faint
Frames ASPIRED as potentially practice-changing, arguing early 14-day ambulatory ECG monitoring should be strongly considered after unexplained syncope. Emphasizes the benefit is in diagnosis and identifying high-risk patients rather than reducing syncope recurrence.
MGMartha GulatiCardiologistPractice takeAug 31
Early monitoring finds actionable arrhythmias even though syncope recurrence was unchanged
Notes the trial enrolled 48% women and that while recurrent syncope did not decrease, arrhythmia detection more than doubled and mortality was lower. Concludes early monitoring finds actionable diagnoses.
Distilled from their postX post
Implication
Immediate 14-day ECG monitoring does not reduce syncope recurrence at 1 year; challenges routine adoption despite higher arrhythmia detection in unexplained syncope.
NEJM · ESC 2026 · RCT. Immediate 14-day ECG monitoring after syncope doesn't reduce recurrence at 1 year. ASPIRED: Immediate Ambulatory Electrocardiographic Monitoring in Syncope Unexplained syncope often goes undiagnosed for months under standard monitoring, delaying treatment of underlying arrhythmias. Does 14-day ambulatory ECG monitoring reduce the mean number of patient-reported episodes of syncope at 1 year in adults with unexplained syncope after emergency department evaluation? 2234 participants, Open-label randomized controlled trial…. Arrhythmia detection: 14-day ECG 22% vs Standard 9%. Read with care. Adverse events were 49 vs 8, with 1 serious adverse event in each arm. The trial was open-label with a self-reported primary outcome whose large standard deviations (±5.10 and ±8.56)… 264 patients (11.8%) with no follow-up were excluded from the primary analysis. Where experts stand: Dr. Matthew J. Reed (Professor of Emergency Medicine · The Usher…): “Although immediate ECG monitoring did not reduce recurrent fainting, it enabled earlier identification of serious cardiac rhythm disorders, allowing…” Martha Gulati (Cardiologist · @drmarthagulati): “@DrDerekConnolly @DLBHATTMD @ESC_President @PZoungas @vass_vassiliou @mmartinezheart @ShelleyZieroth @robmentz @JennaSkowronski @noshreza…” From their public comments on the paper Still open: Should the mortality difference change practice despite a neutral primary endpoint? Read the evidence. See where experts stand. synapsesocial.com/papers/6a8fbb6617152b56e6b6483a
Key Points
- To assess whether immediate 14-day ambulatory electrocardiographic (ECG) monitoring reduces recurrent syncope episodes at 1 year in patients presenting to the emergency department with unexplained syncope.
- Open-label, randomized controlled trial conducted across 45 hospitals in the United Kingdom (ISRCTN10278811).
- Enrolled 2234 adults with syncope unexplained after emergency department evaluation, randomly assigned 1:1 to receive 14-day ambulatory ECG monitoring (N=1123) or standard care (N=1111), with 1-year follow-up.
- In the primary analysis (N=1970), the mean (±SD) number of patient-reported syncope episodes at 1 year was 1.37±5.10 in the intervention group versus 1.58±8.56 in the standard-care group (incidence rate ratio, 0.89; 95% CI, 0.68 to 1.18; P=0.42).
- Adverse events occurred in 49 patients in the 14-day monitoring group versus 8 patients in the standard-care group, with 1 serious adverse event reported in each arm.
Evidence details
What drove the result?
| Outcome | 14-day ECG | Standard |
|---|---|---|
| Patient-reported syncope episodes at 1 year (mean) | 1.37 | 1.58 |
| Primary · IRR 0.89 (95% CI 0.68–1.18; p=0.42) — no significant reduction | ||
| Arrhythmia detection | 22% | 9% |
| From the trial record; not reported in the publication abstract | ||
| All-cause mortality | 1.5% | 2.9% |
| From the trial record, not the abstract · hypothesis-generating only | ||
Limitations & tradeoffs
Safety
Adverse events were 49 vs 8, with 1 serious adverse event in each arm.
Design limitations
The trial was open-label with a self-reported primary outcome whose large standard deviations (±5.10 and ±8.56) indicate highly skewed episode counts.
Statistical certainty
264 patients (11.8%) with no follow-up were excluded from the primary analysis.
Subgroup caution
Arrhythmia-detection and mortality figures come from the trial record rather than the publication abstract.
Structured PICO
Does 14-day ambulatory ECG monitoring reduce the mean number of patient-reported episodes of syncope at 1 year in adults with unexplained syncope after emergency department evaluation?
P
Population
2,234 adults with unexplained syncope after emergency department evaluation, randomized to 14-day ambulatory ECG monitoring or standard care, followed for 1 year.
I
Intervention
14-day ambulatory electrocardiographic (ECG) monitoring
C
Comparator
Standard care provided for patients with unexplained syncope at each participating site
O
Outcome
Mean number of patient-reported episodes of syncope at 1 yearpatient reported
Main Result
Relative Risk: 0.89 (95% CI 0.68–1.18)
Absolute Event Rate: 1.37% vs 1.58%
p-value: p=0.42
In patients with unexplained syncope after emergency department evaluation, 14-day ambulatory ECG monitoring did not significantly reduce patient-reported syncope episodes at 1 year compared to standard care.
Coverage & sources
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Cite This Study
Reed et al. (2026) conducted an RCT in Unexplained syncope (n=2,234). 14-day ambulatory electrocardiographic (ECG) monitoring vs. Standard care was evaluated on Mean number of patient-reported episodes of syncope at 1 year (IRR 0.89, 95% CI 0.68 to 1.18, p=0.42). 14-day ambulatory ECG monitoring did not significantly reduce the mean number of patient-reported syncope episodes at 1 year compared to standard care (IRR 0.89; 95% CI 0.68-1.18; P=0.42).